Prime Clinical Laboratory INC.
Prime Clinical Laboratory INC. was paid $172K by Medicaid between Jan 2018 and Jan 2023, across 21 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 71% of everything it billed.
PALM DESERT, CA 92260
Next to other Clinical Medical Laboratory providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,890 | $656.80 | |
| 2021 | 3,773 | $97K | |
| 2022 | 2,491 | $74K | |
| 2023 | 20 | $324.00 |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 71% | 1,951 | 1,171 | $122K |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | 16% | 1,938 | 1,160 | $28K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 11% | 1,769 | 1,065 | $19K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | <1% | 62 | 62 | $1K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 480 | 417 | $651.54 |
| 80053 | Comprehensive metabolic panel | <1% | 300 | 268 | $219.28 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 188 | 181 | $166.06 |
| 84439 | <1% | 258 | 234 | $149.20 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 77 | 73 | $44.86 |
| 80061 | Lipid panel | <1% | 285 | 258 | $31.17 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 323 | 295 | $25.26 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 270 | 244 | $13.28 |
9 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 176 | $7.69 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 12 | $0.00 |
| 87653 | 0% | 12 | $0.00 | |
| 87641 | 0% | 12 | $0.00 | |
| 87481 | 0% | 12 | $0.00 | |
| 87640 | 0% | 12 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 12 | $0.00 |
| 81001 | 0% | 13 | $0.00 | |
| 87500 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.